CP-724714

DB12302InvestigationalSmall molecule

CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.

Mechanism: Pharmacologically active on Receptor tyrosine-protein kinase erbB-2
Curator reviewed
Formula / weight: C₂₇H₂₇N₅O₃ · 469.545 g/mol (avg)
Code names: CP-724,714

Resolves to

Compound

Structure

InChIKeyLLVZBTWPGQVVLW-SNAWJCMRSA-NSMILESCOCC(=O)NC\C=C\C1=CC=C2N=CN=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)C2=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with CP-724714, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.